>>ALXN acquires GEVA for $226/sh* in cash and stock However much the bears scream about biotech being a bubble, as long as the sector gets support from buyouts like this, it will continue strong. We still haven't seen any moves by GILD - their billions must be burning a hole in their very deep pockets. Maybe we should have a contest to see who GILD will buy (it's going to be more than one company I suspect). Peter